ロード中...
RGD-Conjugated Resveratrol HSA Nanoparticles as a Novel Delivery System in Ovarian Cancer Therapy
BACKGROUND: To establish a novel delivery system of RGD-conjugated resveratrol human serum albumin (HAS) nanoparticles in ovarian cancer therapy. METHODS: The nanoparticles system was characterized for physicochemical properties, the stability in the serum and in vitro release. The comparison betwee...
保存先:
| 出版年: | Drug Des Devel Ther |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7779302/ https://ncbi.nlm.nih.gov/pubmed/33408463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S248950 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|